My watch list  

Triple reuptake inhibitors

Triple reuptake inhibitors (TRIs) are a relatively new class of antidepressants which are currently undergoing clinical trials for treatment of depression, anxiety disorders and some personality disorders.

TRIs target all three of the brain's major neurotransmitters: serotonin, dopamine and noradrenaline.

See also

  • Clinical depression
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Triple_reuptake_inhibitors". A list of authors is available in Wikipedia.
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE